{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:28:23Z","timestamp":1792027703242,"version":"4.4.0"},"reference-count":270,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:00:00Z","timestamp":1633305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Overlapping pandemics of lifestyle-related diseases pose a substantial threat to cardiovascular health. Apart from coronary artery disease, metabolic disturbances linked to obesity, insulin resistance and diabetes directly compromise myocardial structure and function through independent and shared mechanisms heavily involving inflammatory signals. Accumulating evidence indicates that metabolic dysregulation causes systemic inflammation, which in turn aggravates cardiovascular disease. Indeed, elevated systemic levels of pro-inflammatory cytokines and metabolic substrates induce an inflammatory state in different cardiac cells and lead to subcellular alterations thereby promoting maladaptive myocardial remodeling. At the cellular level, inflammation-induced oxidative stress, mitochondrial dysfunction, impaired calcium handling, and lipotoxicity contribute to cardiomyocyte hypertrophy and dysfunction, extracellular matrix accumulation and microvascular disease. In cardiometabolic patients, myocardial inflammation is maintained by innate immune cell activation mediated by pattern recognition receptors such as Toll-like receptor 4 (TLR4) and downstream activation of the NLRP3 inflammasome and NF-\u03baB-dependent pathways. Chronic low-grade inflammation progressively alters metabolic processes in the heart, leading to a metabolic cardiomyopathy (MC) phenotype and eventually to heart failure with preserved ejection fraction (HFpEF). In accordance with preclinical data, observational studies consistently showed increased inflammatory markers and cardiometabolic features in patients with HFpEF. Future treatment approaches of MC may target inflammatory mediators as they are closely intertwined with cardiac nutrient metabolism. Here, we review current evidence on inflammatory processes involved in the development of MC and provide an overview of nutrient and cytokine-driven pro-inflammatory effects stratified by cell type.<\/jats:p>","DOI":"10.3389\/fcvm.2021.742178","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:52:20Z","timestamp":1633308740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":99,"title":["Inflammation in Metabolic Cardiomyopathy"],"prefix":"10.3389","volume":"8","author":[{"given":"Florian A.","family":"Wenzl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafeeq A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kraler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ijo.2008.102","article-title":"Global burden of obesity in 2005 and projections to 2030","volume":"32","author":"Kelly","year":"2008","journal-title":"Int J Obes."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.jacc.2021.02.030","article-title":"Causes and risk factors for death in diabetes: a competing-risk analysis from the SAVOR-TIMI 53 trial","volume":"77","author":"Cavallari","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","article-title":"Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK","volume":"6","author":"Bhaskaran","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Sanchis-Gomar","year":"2016","journal-title":"Ann Transl Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1507\/endocrj.K08E-026","article-title":"Elevated high sensitivity C-reactive protein is associated with type 2 diabetes mellitus: the Persian Gulf Healthy Heart Study","volume":"55","author":"Nabipour","year":"2008","journal-title":"Endocr J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1001\/jama.282.22.2131","article-title":"Elevated C-reactive protein levels in overweight and obese adults","volume":"282","author":"Visser","year":"1999","journal-title":"J Am Med Assoc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","article-title":"Myocardial gene expression signatures in human heart failure with preserved ejection fraction","volume":"143","author":"Hahn","year":"2021","journal-title":"Circulation."},{"key":"B11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)","volume":"113","author":"Van Tassell","year":"2014","journal-title":"Am J Cardiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e005036","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ Heart Fail."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/cvr\/cvx012","article-title":"Inflammation and metabolic cardiomyopathy","volume":"113","author":"Nishida","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/cvr\/cvx008","article-title":"Sex differences in metabolic cardiomyopathy","volume":"113","author":"Murphy","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/eurheartj\/ehy903","article-title":"Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy","volume":"40","author":"Costantino","year":"2019","journal-title":"Eur Heart J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCRESAHA.116.306842","article-title":"Lipid use and misuse by the heart","volume":"118","author":"Schulze","year":"2016","journal-title":"Circ Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jcmg.2017.04.001","article-title":"Subclinical myocardial impairment in metabolic diseases","volume":"10","author":"Kosmala","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2011.08.080","article-title":"Pre-diabetes, metabolic syndrome, and cardiovascular risk","volume":"59","author":"Grundy","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000064682","article-title":"Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy","volume":"98","author":"Schannwell","year":"2002","journal-title":"Cardiology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham Study","volume":"22","author":"Ho","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","article-title":"Metabolic inflammation in heart failure with preserved ejection fraction","volume":"117","author":"Schiattarella","year":"2021","journal-title":"Cardiovasc Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science."},{"key":"B29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.lfs.2012.10.028","article-title":"Molecular and metabolic mechanisms of cardiac dysfunction in diabetes","volume":"92","author":"Mandavia","year":"2013","journal-title":"Life Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1042\/CS20160005","article-title":"Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?","volume":"130","author":"Bl\u00fcher","year":"2016","journal-title":"Clin Sci (Lond)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nm.3800","article-title":"LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes","volume":"21","author":"Li","year":"2015","journal-title":"Nat Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3389\/fimmu.2015.00637","article-title":"The macrophage switch in obesity development","volume":"6","author":"Castoldi","year":"2016","journal-title":"Front Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ijo.2009.133","article-title":"Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue","volume":"33","author":"O'Rourke","year":"2009","journal-title":"Int J Obes."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1210\/jc.2002-020696","article-title":"Metabolic effects of visceral fat accumulation in type 2 diabetes","volume":"87","author":"Gastaldelli","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/01.CIR.95.5.1247","article-title":"Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes","volume":"95","author":"Yokoyama","year":"1997","journal-title":"Circulation."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1172\/JCI119114","article-title":"Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death","volume":"98","author":"Krown","year":"1996","journal-title":"J Clin Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF03347084","article-title":"PPAR\u03b1 agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes","volume":"34","author":"Nan","year":"2011","journal-title":"J Endocrinol Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1475-2840-8-8","article-title":"The signal transduction pathway of PKC\/NF-kappa B\/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats","volume":"8","author":"Min","year":"2009","journal-title":"Cardiovasc Diabetol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00395-010-0114-3","article-title":"HMGB1: the missing link between diabetes mellitus and heart failure","volume":"105","author":"Volz","year":"2010","journal-title":"Basic Res Cardiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"H1905","DOI":"10.1152\/ajpheart.00445.2011","article-title":"The roles of O-linked \u03b2-N-acetylglucosamine in cardiovascular physiology and disease","volume":"302","author":"Zachara","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"H833","DOI":"10.1152\/ajpheart.00418.2009","article-title":"Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy","volume":"298","author":"Sulaiman","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvq376","article-title":"Sirt1 acts in association with PPAR\u03b1 to protect the heart from hypertrophy, metabolic dysregulation, and inflammation","volume":"90","author":"Planavila","year":"2011","journal-title":"Cardiovasc Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2337\/db13-1577","article-title":"Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy","volume":"63","author":"Pan","year":"2014","journal-title":"Diabetes."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2337\/db08-1697","article-title":"Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling","volume":"58","author":"Wang","year":"2009","journal-title":"Diabetes."},{"key":"B47","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/HYPERTENSIONAHA.114.04737","article-title":"Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet","volume":"65","author":"Jia","year":"2015","journal-title":"Hypertension."},{"key":"B48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jacbts.2020.11.012","article-title":"Novel G\u00f6ttingen Miniswine model of heart failure with preserved ejection fraction integrating multiple comorbidities","volume":"6","author":"Sharp","year":"2021","journal-title":"JACC Basic Transl Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.2337\/db08-1361","article-title":"Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart","volume":"58","author":"Ko","year":"2009","journal-title":"Diabetes."},{"key":"B50","doi-asserted-by":"publisher","first-page":"E323","DOI":"10.1152\/ajpendo.00024.2008","article-title":"Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs","volume":"295","author":"Tikellis","year":"2008","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B51","doi-asserted-by":"publisher","first-page":"H762","DOI":"10.1152\/ajpheart.00367.2014","article-title":"BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy","volume":"307","author":"Urbina","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/HJH.0b013e32833366cd","article-title":"Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice","volume":"28","author":"Fukuda","year":"2010","journal-title":"J Hypertens."},{"key":"B53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1124\/jpet.110.170373","article-title":"Ezetimibe ameliorates cardiovascular complications and hepatic steatosis in obese and type 2 diabetic db\/db mice","volume":"335","author":"Fukuda","year":"2010","journal-title":"J Pharmacol Exp Ther."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.2337\/db06-1662","article-title":"Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1096\/fj.05-4095fje","article-title":"Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy","volume":"19","author":"Tsch\u00f6pe","year":"2005","journal-title":"FASEB J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"H1366","DOI":"10.1152\/ajpheart.00111.2012","article-title":"Macrophages modulate cardiac function in lipotoxic cardiomyopathy","volume":"303","author":"Schilling","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jchf.2015.10.007","article-title":"Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction","volume":"4","author":"Franssen","year":"2016","journal-title":"JACC Heart Fail."},{"key":"B58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fendo.2013.00052","article-title":"Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies","volume":"4","author":"McArdle","year":"2013","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B59","doi-asserted-by":"publisher","first-page":"16683","DOI":"10.1074\/jbc.M011695200","article-title":"Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem."},{"key":"B60","doi-asserted-by":"publisher","first-page":"35279","DOI":"10.1074\/jbc.M706762200","article-title":"A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways","volume":"282","author":"Nguyen","year":"2007","journal-title":"J Biol Chem."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cmet.2018.03.014","article-title":"Evidence that TLR4 is not a receptor for saturated fatty acids but mediates lipid-induced inflammation by reprogramming macrophage metabolism","volume":"27","author":"Lancaster","year":"2018","journal-title":"Cell Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jchf.2018.01.009","article-title":"Obesity-related heart failure with a preserved ejection fraction: the mechanistic rationale for combining inhibitors of aldosterone, neprilysin, and sodium-glucose cotransporter-2","volume":"6","author":"Packer","year":"2018","journal-title":"JACC Heart Fail."},{"key":"B63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11906-008-0019-9","article-title":"Local adipose tissue renin-angiotensin system","volume":"10","author":"Cassis","year":"2008","journal-title":"Curr Hypertens Rep."},{"key":"B65","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1042\/CS20080390","article-title":"Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction","volume":"116","author":"Sciarretta","year":"2009","journal-title":"Clin Sci."},{"key":"B66","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/01.ATV.20.3.645","article-title":"Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress","volume":"20","author":"Pueyo","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/HYPERTENSIONAHA.117.10280","article-title":"Favorable vascular actions of angiotensin-(1-7) in human obesity","volume":"71","author":"Schinzari","year":"2018","journal-title":"Hypertension."},{"key":"B68","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Sim\u00f5es e Silva","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation","volume":"126","author":"Mouton AJ Li","year":"2020","journal-title":"Circ Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"732450","DOI":"10.1155\/2015\/732450","article-title":"Advanced glycation end products enhance macrophages polarization into M1 phenotype through activating RAGE\/NF-\u03baB pathway","volume":"2015","author":"Jin","year":"2015","journal-title":"Biomed Res Int."},{"key":"B71","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1152\/ajpendo.00093.2009","article-title":"The Randle cycle revisited: a new head for an old hat","volume":"297","author":"Hue","year":"2009","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.2337\/db10-0704","article-title":"Activation of peroxisome proliferator-activated receptor-\u03b2\/-\u03b4 (PPAR-\u03b2\/-\u03b4) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes","volume":"60","author":"Serrano-Marco","year":"2011","journal-title":"Diabetes."},{"key":"B73","doi-asserted-by":"publisher","first-page":"R885","DOI":"10.1152\/ajpregu.00316.2011","article-title":"Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities","volume":"301","author":"Pulakat","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2567.2002.01404.x","article-title":"Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid","volume":"106","author":"Han","year":"2002","journal-title":"Immunology."},{"key":"B75","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jacc.2005.09.030","article-title":"Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus","volume":"47","author":"Herrero","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation."},{"key":"B77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/jcp.26.4.285","article-title":"Triglycerides, cholesterol, and phospholipids in normal heart papillary muscle and in patients suffering from diabetes, cholelithiasis, hypertension, and coronary atheroma","volume":"26","author":"Alavaikko","year":"1973","journal-title":"J Clin Pathol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"14890","DOI":"10.1074\/jbc.M010286200","article-title":"Palmitate-induced apoptosis can occur through a ceramide-independent pathway","volume":"276","author":"Listenberger","year":"2001","journal-title":"J Biol Chem."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1194\/jlr.P900032-JLR200","article-title":"Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome","volume":"50","author":"Marfella","year":"2009","journal-title":"J Lipid Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1006\/jmcc.1999.1098","article-title":"Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes","volume":"32","author":"Hickson-Bick","year":"2000","journal-title":"J Mol Cell Cardiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"H2124","DOI":"10.1152\/ajpheart.2000.279.5.H2124","article-title":"A. metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis","volume":"279","author":"Sparagna","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.2337\/diabetes.54.12.3530","article-title":"Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL\/6 mice","volume":"54","author":"Park","year":"2005","journal-title":"Diabetes."},{"key":"B84","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fcvm.2020.00012","article-title":"Mitochondrial ROS formation in the pathogenesis of diabetic cardiomyopathy","volume":"7","author":"Kaludercic","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet.2010.12.008","article-title":"NF-\u03baB, inflammation, and metabolic disease","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-\u03baB in the heart: to be or not to NF-\u03baB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","article-title":"Molecular and cellular mechanisms of cardiovascular disorders in diabetes","volume":"118","author":"Shah","year":"2016","journal-title":"Circ Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2337\/db10-1164","article-title":"Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"key":"B89","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.yjmcc.2015.10.010","article-title":"Cardiac-specific overexpression of catalase prevents diabetes-induced pathological changes by inhibiting NF-\u03baB signaling activation in the heart","volume":"89","author":"Cong","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"H1036","DOI":"10.1152\/ajpheart.00340.2014","article-title":"Cardiac-specific suppression of NF-\u03baB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system","volume":"307","author":"Thomas","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"8891","DOI":"10.1007\/s11033-012-1756-z","article-title":"High levels of glucose induce \u201cmetabolic memory\u201d in cardiomyocyte via epigenetic histone H3 lysine 9 methylation","volume":"39","author":"Yu","year":"2012","journal-title":"Mol Biol Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"17345","DOI":"10.1073\/pnas.0806198105","article-title":"NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions","volume":"105","author":"Yang","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia","volume":"205","author":"El-Osta","year":"2008","journal-title":"J Exp Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbalip.2010.11.002","article-title":"PPAR\u03b2\/\u03b4 activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells","volume":"1811","author":"Alvarez-Guardia","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B95","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejphar.2018.05.003","article-title":"Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells","volume":"831","author":"Li","year":"2018","journal-title":"Eur J Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ajpath.2019.11.004","article-title":"Endothelial cell calcium signaling during barrier function and inflammation","volume":"190","author":"Dalal","year":"2020","journal-title":"Am J Pathol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/3-540-36028-X_2","article-title":"Vascular endothelium and blood flow","volume":"176","author":"Busse","year":"2006","journal-title":"Handb Exp Pharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3634948","DOI":"10.1155\/2016\/3634948","article-title":"Insulin resistance and endothelial dysfunction constitute a common therapeutic target in cardiometabolic disorders","volume":"2016","author":"Janus","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B99","doi-asserted-by":"publisher","first-page":"792393","DOI":"10.1155\/2010\/792393","article-title":"Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus","volume":"2010","author":"van den Oever","year":"2010","journal-title":"Mediators Inflamm."},{"key":"B100","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.yjmcc.2005.05.009","article-title":"Activation of IKKbeta by glucose is necessary and sufficient to impair insulin signaling and nitric oxide production in endothelial cells","volume":"39","author":"Kim","year":"2005","journal-title":"J Mol Cell Cardiol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00125-009-1272-4","article-title":"Endothelial inflammation induced by excess glucose is associated with cytosolic glucose 6-phosphate but not increased mitochondrial respiration","volume":"52","author":"Sweet","year":"2009","journal-title":"Diabetologia."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00109-016-1481-5","article-title":"Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction","volume":"94","author":"Chen","year":"2016","journal-title":"J Mol Med (Berl)."},{"key":"B103","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-021-01222-9","article-title":"Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA","volume":"20","author":"Paolisso","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/jcp.29064","article-title":"MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients","volume":"235","author":"D'Onofrio","year":"2020","journal-title":"J Cell Physiol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12929-017-0357-5","article-title":"Role of free fatty acids in endothelial dysfunction","volume":"24","author":"Ghosh","year":"2017","journal-title":"J Biomed Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1161\/CIRCRESAHA.106.142851","article-title":"Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity","volume":"100","author":"Kim","year":"2007","journal-title":"Circ Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijcard.2010.07.019","article-title":"Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-\u03baB pathway in rat aorta","volume":"152","author":"Li","year":"2011","journal-title":"Int J Cardiol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e29600","DOI":"10.1371\/journal.pone.0029600","article-title":"Trans fatty acids induce vascular inflammation and reduce vascular nitric oxide production in endothelial cells","volume":"6","author":"Iwata","year":"2011","journal-title":"PLoS ONE."},{"key":"B109","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ajcn\/75.1.119","article-title":"Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells","volume":"75","author":"Toborek","year":"2002","journal-title":"Am J Clin Nutr."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCULATIONAHA.111.054346","article-title":"Blockade of the nuclear factor-\u03baB pathway in the endothelium prevents insulin resistance and prolongs life spans","volume":"125","author":"Hasegawa","year":"2012","journal-title":"Circulation."},{"key":"B111","doi-asserted-by":"publisher","first-page":"116882","DOI":"10.1016\/j.lfs.2019.116882","article-title":"NLRP3 inflammasome mediate palmitate-induced endothelial dysfunction","volume":"239","author":"Xing JH Li","year":"2019","journal-title":"Life Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J Mol Cell Cardiol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1681\/ASN.V1091891","article-title":"High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta","volume":"10","author":"Han","year":"1999","journal-title":"J Am Soc Nephrol."},{"key":"B115","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1139\/cjpp-2013-0490","article-title":"Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts","volume":"92","author":"Shamhart","year":"2014","journal-title":"Can J Physiol Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"C794","DOI":"10.1152\/ajpcell.00251.2013","article-title":"Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis","volume":"306","author":"Aguilar","year":"2014","journal-title":"Am J Physiol Cell Physiol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"7769","DOI":"10.1002\/jcp.29386","article-title":"Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts","volume":"235","author":"Che","year":"2020","journal-title":"J Cell Physiol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/ijms21030970","article-title":"The diabetic cardiac fibroblast: mechanisms underlying phenotype and function","volume":"21","author":"Levick","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"H2078","DOI":"10.1152\/ajpheart.01363.2007","article-title":"Resveratrol inhibits high glucose-induced PI3K\/Akt\/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts","volume":"294","author":"Venkatachalam","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11010-006-9401-6","article-title":"High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1\/2","volume":"301","author":"Tang","year":"2007","journal-title":"Mol Cell Biochem."},{"key":"B121","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11626-007-9052-2","article-title":"Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix","volume":"43","author":"Zhang","year":"2007","journal-title":"In vitro Cell Dev Biol Anim"},{"key":"B122","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12872-015-0169-z","article-title":"Resveratrol ameliorates myocardial fibrosis by inhibiting ROS\/ERK\/TGF-\u03b2\/periostin pathway in STZ-induced diabetic mice","volume":"16","author":"Wu","year":"2016","journal-title":"BMC Cardiovasc Disord."},{"key":"B123","doi-asserted-by":"publisher","first-page":"H934","DOI":"10.1152\/ajpheart.00238.2018","article-title":"Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction","volume":"315","author":"Alex","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/cells10010051","article-title":"Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair","volume":"10","author":"Lafuse","year":"2020","journal-title":"Cells."},{"key":"B125","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.yjmcc.2015.11.015","article-title":"Monocyte and macrophage contributions to cardiac remodeling","volume":"93","author":"Hulsmans","year":"2016","journal-title":"J Mol Cell Cardiol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest."},{"key":"B127","doi-asserted-by":"publisher","first-page":"7884","DOI":"10.1074\/jbc.M113.522037","article-title":"Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype","volume":"289","author":"reemerman","year":"2014","journal-title":"J Biol Chem"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e123047","DOI":"10.1172\/jci.insight.123047","article-title":"Glucose metabolism controls disease-specific signatures of macrophage effector functions","volume":"3","author":"Watanabe","year":"2018","journal-title":"JCI Insight."},{"key":"B129","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2017.00289","article-title":"Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity","volume":"8","author":"Geeraerts","year":"2017","journal-title":"Front Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","article-title":"Obesity and free fatty acids","volume":"37","author":"Boden","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B131","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.bbalip.2016.09.002","article-title":"Macrophage fatty acid oxidation and its roles in macrophage polarization and fatty acid-induced inflammation","volume":"1861","author":"Namgaladze","year":"2016","journal-title":"Biochim Biophys Acta."},{"key":"B133","doi-asserted-by":"publisher","first-page":"29402","DOI":"10.1074\/jbc.M115.680199","article-title":"Macrophage-specific de novo synthesis of ceramide is dispensable for inflammasome-driven inflammation and insulin resistance in obesity","volume":"290","author":"Camell","year":"2015","journal-title":"J Biol Chem."},{"key":"B134","doi-asserted-by":"publisher","first-page":"508409","DOI":"10.1155\/2015\/508409","article-title":"Mechanisms linking inflammation to insulin resistance","volume":"2015","author":"Chen","year":"2015","journal-title":"Int J Endocrinol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation."},{"key":"B136","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/cvr\/cvp040","article-title":"IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis","volume":"82","author":"Dhingra","year":"2009","journal-title":"Cardiovasc Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"key":"B139","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","article-title":"Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha","volume":"81","author":"Kubota","year":"1997","journal-title":"Circ Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1172\/JCI117956","article-title":"Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture","volume":"95","author":"Palmer","year":"1995","journal-title":"J Clin Invest."},{"key":"B142","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1161\/01.CIR.98.8.794","article-title":"Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II","volume":"98","author":"Nakamura","year":"1998","journal-title":"Circulation."},{"key":"B143","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1126\/science.1631560","article-title":"Negative inotropic effects of cytokines on the heart mediated by nitric oxide","volume":"257","author":"Finkel","year":"1992","journal-title":"Science."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1172\/JCI29134","article-title":"provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways","volume":"117","author":"Haudek","year":"2007","journal-title":"J Clin Invest."},{"key":"B145","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1359\/JBMR.051027","article-title":"Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts","volume":"21","author":"Kindle","year":"2006","journal-title":"J Bone Miner Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"C767","DOI":"10.1152\/ajpcell.1992.263.4.C767","article-title":"Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC","volume":"263","author":"Myers","year":"1992","journal-title":"Am J Physiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"R556","DOI":"10.1152\/ajpregu.90817.2008","article-title":"Mechanisms of coronary microvascular adaptation to obesity","volume":"297","author":"Bagi","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"8173816","DOI":"10.1155\/2016\/8173816","article-title":"Obesity related coronary microvascular dysfunction: from basic to clinical practice","volume":"2016","author":"Selthofer-Relati\u0107","year":"2016","journal-title":"Cardiol Res Pract."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1096\/fj.99-0910com","article-title":"Rac1 inhibits TNF-alpha-induced endothelial cell apoptosis: dual regulation by reactive oxygen species","volume":"14","author":"Deshpande","year":"2000","journal-title":"FASEB J."},{"key":"B150","doi-asserted-by":"publisher","first-page":"14414","DOI":"10.1074\/jbc.M809757200","article-title":"WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death","volume":"284","author":"Venkatachalam","year":"2009","journal-title":"J Biol Chem."},{"key":"B151","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bbrc.2011.08.109","article-title":"TNF-\u03b1 increases cardiac fibroblast lysyl oxidase expression through TGF-\u03b2 and PI3Kinase signaling pathways","volume":"413","author":"Voloshenyuk","year":"2011","journal-title":"Biochem Biophys Res Commun."},{"key":"B152","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1161\/01.RES.86.12.1259","article-title":"Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro","volume":"86","author":"Siwik","year":"2000","journal-title":"Circ Res."},{"key":"B153","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1172\/JCI118095","article-title":"Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes","volume":"96","author":"Thaik","year":"1995","journal-title":"J Clin Invest."},{"key":"B155","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1161\/CIRCRESAHA.109.208199","article-title":"Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways","volume":"105","author":"Honsho","year":"2009","journal-title":"Circ Res."},{"key":"B156","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/01.RES.84.1.21","article-title":"Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x","volume":"84","author":"Ing","year":"1999","journal-title":"Circ Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12933-015-0288-y","article-title":"Circulating interleukin-1\u03b2 promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2","volume":"14","author":"Liu","year":"2015","journal-title":"Cardiovasc Diabetol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/08977194.2013.787994","article-title":"IL-1\u03b2 suppresses TGF-\u03b2-mediated myofibroblast differentiation in cardiac fibroblasts","volume":"31","author":"Br\u00f8nnum","year":"2013","journal-title":"Growth Factors."},{"key":"B159","doi-asserted-by":"publisher","first-page":"17005","DOI":"10.1038\/s41598-018-35429-w","article-title":"IL-1\u03b2- and IL-4-polarized macrophages have opposite effects on adipogenesis of intramuscular fibro-adipogenic progenitors in humans","volume":"8","author":"Moratal","year":"2018","journal-title":"Sci Rep."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1161\/CIRCRESAHA.116.308688","article-title":"Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction","volume":"118","author":"Zhao","year":"2016","journal-title":"Circ Res."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1161\/CIRCRESAHA.116.309685","article-title":"Titin-based cardiac myocyte stiffening contributes to early adaptive ventricular remodeling after myocardial infarction","volume":"119","author":"K\u00f6tter","year":"2016","journal-title":"Circ Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1023\/A:1011401825680","article-title":"The role of interleukin-6 in the failing heart","volume":"6","author":"Wollert","year":"2001","journal-title":"Heart Fail Rev."},{"key":"B163","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1365-2249.1996.d01-717.x","article-title":"IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes","volume":"105","author":"Watson","year":"1996","journal-title":"Clin Exp Immunol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"23010","DOI":"10.1038\/srep23010","article-title":"Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGF\u03b21 and miR-29 pathways","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.4049\/jimmunol.1600476","article-title":"IL-6 regulates M2 polarization and local proliferation of adipose tissue macrophages in obesity","volume":"198","author":"Braune","year":"2017","journal-title":"J Immunol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.bbadis.2017.01.006","article-title":"IL-6 promotes M2 macrophage polarization by modulating purinergic signaling and regulates the lethal release of nitric oxide during Trypanosoma cruzi infection","volume":"1863","author":"Sanmarco","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"B167","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yjmcc.2014.07.007","article-title":"Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model IL-18 potentiates TNF-\u03b1-induced cardiomyocyte death","volume":"75","author":"Yoshida","year":"2014","journal-title":"J Mol Cell Cardiol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"37069","DOI":"10.1074\/jbc.M103574200","article-title":"A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways","volume":"276","author":"Morel","year":"2001","journal-title":"J Biol Chem."},{"key":"B169","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1084\/jem.20011022","article-title":"Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis","volume":"195","author":"Gerdes","year":"2002","journal-title":"J Exp Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.bbrc.2005.11.100","article-title":"Interleukin-18 induces human cardiac endothelial cell death via a novel signaling pathway involving NF-kappaB-dependent PTEN activation","volume":"339","author":"handrasekar","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"B171","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cyto.2010.10.002","article-title":"Effects of interleukin-18 on cardiac fibroblast function and gene expression","volume":"53","author":"Fix","year":"2011","journal-title":"Cytokine."},{"key":"B172","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3389\/fimmu.2018.00334","article-title":"Interleukin-18 amplifies macrophage polarization and morphological alteration, leading to excessive angiogenesis","volume":"9","author":"Kobori","year":"2018","journal-title":"Front Immunol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz Jel","year":"2002","journal-title":"J Clin Invest."},{"key":"B174","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cardiores.2005.02.021","article-title":"SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes","volume":"67","author":"Schneiders","year":"2005","journal-title":"Cardiovasc Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/jcp.22619","article-title":"TGF\u03b2 receptor activation enhances cardiac apoptosis via SMAD activation and concomitant NO release","volume":"226","author":"Heger","year":"2011","journal-title":"J Cell Physiol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fcell.2020.00260","article-title":"TGF-\u03b2-induced endothelial to mesenchymal transition in disease and tissue engineering","volume":"8","author":"Ma","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/ki.1997.192","article-title":"TGF-beta and the endothelium during immune injury","volume":"51","author":"Pintavorn","year":"1997","journal-title":"Kidney Int."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1161\/01.ATV.15.8.1255","article-title":"Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1","volume":"15","author":"Inoue","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/1541-7786.MCR-11-0507","article-title":"TGF-\u03b21 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38\u03b2 to proapoptotic p38\u03b1","volume":"10","author":"Ferrari","year":"2012","journal-title":"Mol Cancer Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1242\/jcs.02587","article-title":"TGF-beta-induced apoptosis in endothelial cells mediated by M6P\/IGFII-R and mini-plasminogen","volume":"118","author":"Leksa","year":"2005","journal-title":"J Cell Sci"},{"key":"B181","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1083\/jcb.122.1.103","article-title":"Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts","volume":"122","author":"Desmouli\u00e8re","year":"1993","journal-title":"J Cell Biol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/CIRCRESAHA.109.216101","article-title":"Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction","volume":"107","author":"Dobaczewski","year":"2010","journal-title":"Circ Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"52294","DOI":"10.18632\/oncotarget.10561","article-title":"TGF-\u03b2 induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/01.CIR.0000140766.52771.6D","article-title":"Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes","volume":"110","author":"Xu","year":"2004","journal-title":"Circulation."},{"key":"B185","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/01.HYP.0000198555.51645.f1","article-title":"Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway","volume":"47","author":"Dong","year":"2006","journal-title":"Hypertension."},{"key":"B186","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/cvr\/cvp071","article-title":"Leptin attenuates cardiac apoptosis after chronic ischaemic injury","volume":"83","author":"McGaffin","year":"2009","journal-title":"Cardiovasc Res."},{"key":"B187","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1111\/j.1742-4658.2008.06465.x","article-title":"Leptin protects H9c2 rat cardiomyocytes from H2O2-induced apoptosis","volume":"275","author":"Eguchi","year":"2008","journal-title":"FEBS J."},{"key":"B188","doi-asserted-by":"publisher","first-page":"H1514","DOI":"10.1152\/ajpheart.00479.2008","article-title":"Leptin-induced endothelial dysfunction in obesity","volume":"295","author":"Korda","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/emm.2001.17","article-title":"Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro","volume":"33","author":"Park","year":"2001","journal-title":"Exp Mol Med."},{"key":"B190","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/biof.5520310310","article-title":"Adiponectin and leptin up-regulate extracellular matrix production by dermal fibroblasts","volume":"31","author":"Ezure","year":"2007","journal-title":"Biofactors."},{"key":"B191","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/sj.bjp.0704903","article-title":"Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A1","volume":"137","author":"Raso","year":"2002","journal-title":"Br J Pharmacol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1210\/jc.81.11.3909","article-title":"Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates","volume":"81","author":"Ostlund","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"B193","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s00125-013-2996-8","article-title":"Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight\/obesity","volume":"56","author":"Wang YC Li","year":"2013","journal-title":"Diabetologia."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.metabol.2005.05.024","article-title":"Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity","volume":"54","author":"Fain","year":"2005","journal-title":"Metabolism."},{"key":"B195","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.phrs.2006.11.002","article-title":"Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels","volume":"55","author":"Di Renzo","year":"2007","journal-title":"Pharmacol Res."},{"key":"B196","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cyto.2015.05.005","article-title":"IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance","volume":"75","author":"Ballak","year":"2015","journal-title":"Cytokine."},{"key":"B197","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1210\/jcem.87.8.8781","article-title":"Weight loss reduces interleukin-18 levels in obese women","volume":"87","author":"Esposito","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"B198","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.imlet.2017.04.003","article-title":"Serum TNF-\u03b1 concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: a systematic review and meta-analysis","volume":"186","author":"Chen","year":"2017","journal-title":"Immunol Lett."},{"key":"B199","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnins.2013.00051","article-title":"The role of leptin in the control of insulin-glucose axis","volume":"7","author":"Amitani","year":"2013","journal-title":"Front Neurosci."},{"key":"B200","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.yexcr.2014.12.011","article-title":"Factors circulating in the blood of type 2 diabetes mellitus patients affect osteoblast maturation - description of a novel in vitro model","volume":"332","author":"Ehnert","year":"2015","journal-title":"Exp Cell Res."},{"key":"B201","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.4049\/jimmunol.1002615","article-title":"Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes","volume":"186","author":"Jagannathan-Bogdan","year":"2011","journal-title":"J Immunol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1475-2840-9-11","article-title":"The role of interleukin-18 in the metabolic syndrome","volume":"9","author":"Tr\u00f8seid","year":"2010","journal-title":"Cardiovasc Diabetol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.108.846105","article-title":"Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction?","volume":"119","author":"Schulz","year":"2009","journal-title":"Circulation."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1096\/fj.02-0419com","article-title":"TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor","volume":"16","author":"Condorelli","year":"2002","journal-title":"FASEB J."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/01.CIR.97.14.1382","article-title":"Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats","volume":"97","author":"Bozkurt","year":"1998","journal-title":"Circulation."},{"key":"B207","doi-asserted-by":"publisher","first-page":"e33438","DOI":"10.1371\/journal.pone.0033438","article-title":"Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure","volume":"7","author":"Van Tassell","year":"2012","journal-title":"PLoS ONE."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation."},{"key":"B209","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","article-title":"Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats","volume":"56","author":"Mel\u00e9ndez","year":"2010","journal-title":"Hypertension."},{"key":"B210","doi-asserted-by":"publisher","first-page":"19725","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B211","doi-asserted-by":"publisher","first-page":"e104771","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PLoS ONE."},{"key":"B212","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jacc.2013.09.052","article-title":"Impaired systolic function by strain imaging in heart failure with preserved ejection fraction","volume":"63","author":"Kraigher-Krainer","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","article-title":"Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes","volume":"41","author":"Di Carli","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2015.08.028","article-title":"Ancient gunpowder and novel insights team up against heart failure with preserved ejection fraction","volume":"66","author":"Paulus","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1177\/0300060516675504","article-title":"Coronary microvascular dysfunction in diabetes mellitus","volume":"45","author":"Kibel","year":"2017","journal-title":"J Int Med Res."},{"key":"B218","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/01.CIR.91.3.635","article-title":"Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus","volume":"91","author":"Nahser","year":"1995","journal-title":"Circulation."},{"key":"B219","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.amjhyper.2007.08.005","article-title":"Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis","volume":"20","author":"Galderisi","year":"2007","journal-title":"Am J Hypertens."},{"key":"B220","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jacc.2018.05.049","article-title":"Coronary microvascular dysfunction and cardiovascular risk in obese patients","volume":"72","author":"Bajaj","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B221","first-page":"391","article-title":"Decreased coronary flow reserve in obese women","volume":"37","author":"Eroglu","year":"2009","journal-title":"Turk Kardiyol Dern Ars."},{"key":"B222","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/01.CIR.0000129772.26647.6F","article-title":"Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance","volume":"109","author":"de Jongh","year":"2004","journal-title":"Circulation."},{"key":"B223","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0735-1097(01)01212-8","article-title":"Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries","volume":"37","author":"Al Suwaidi","year":"2001","journal-title":"J Am Coll Cardiol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/eurheartj\/ehx721","article-title":"Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction","volume":"39","author":"Taqueti","year":"2018","journal-title":"Eur Heart J."},{"key":"B225","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/eurheartj\/ehy531","article-title":"Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF","volume":"39","author":"Shah","year":"2018","journal-title":"Eur Heart J."},{"key":"B226","doi-asserted-by":"publisher","first-page":"e002562","DOI":"10.1161\/CIRCHEARTFAILURE.115.002562","article-title":"Reduced myocardial flow in heart failure patients with preserved ejection fraction","volume":"9","author":"Srivaratharajah","year":"2016","journal-title":"Circ Heart Fail."},{"key":"B227","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/eurheartj\/ehi356","article-title":"Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease","volume":"26","author":"Tomai","year":"2005","journal-title":"Eur Heart J."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/eurheartj\/ehw018","article-title":"Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases","volume":"37","author":"Faccini","year":"2016","journal-title":"Eur Heart J."},{"key":"B229","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jcmg.2013.02.005","article-title":"Inflammation, coronary flow reserve, and microvascular dysfunction: moving beyond cardiac syndrome X","volume":"6","author":"Taqueti","year":"2013","journal-title":"JACC Cardiovasc Imaging."},{"key":"B230","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","article-title":"High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries)","volume":"59","author":"Ong","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jacc.2010.09.074","article-title":"Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins","volume":"57","author":"Vaccarino","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.numecd.2013.09.021","article-title":"Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease","volume":"24","author":"Tona","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B233","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jcmg.2012.01.020","article-title":"Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation","volume":"5","author":"Quercioli","year":"2012","journal-title":"JACC Cardiovasc Imaging."},{"key":"B234","doi-asserted-by":"publisher","first-page":"e81798","DOI":"10.1371\/journal.pone.0081798","article-title":"Obesity is associated with lower coronary microvascular density","volume":"8","author":"Campbell","year":"2013","journal-title":"PLoS ONE."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1113\/EP086416","article-title":"Exercise training dose differentially alters muscle and heart capillary density and metabolic functions in an obese rat with metabolic syndrome","volume":"102","author":"Machado","year":"2017","journal-title":"Exp Physiol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/CIRCRESAHA.113.302593","article-title":"Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation","volume":"113","author":"Gonzalez-Quesada","year":"2013","journal-title":"Circ Res."},{"key":"B237","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.amjhyper.2003.10.006","article-title":"Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats","volume":"17","author":"Toblli","year":"2004","journal-title":"Am J Hypertens."},{"key":"B238","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur Heart J"},{"key":"B239","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.biopha.2017.07.129","article-title":"Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats","volume":"94","author":"Othman","year":"2017","journal-title":"Biomed Pharmacother."},{"key":"B240","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol."},{"key":"B241","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cardiores.2005.02.020","article-title":"Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3","volume":"67","author":"Singh","year":"2005","journal-title":"Cardiovasc Res."},{"key":"B242","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/0092-8674(89)90775-7","article-title":"Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes","volume":"59","author":"Osborn","year":"1989","journal-title":"Cell."},{"key":"B243","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/hy1201.100589","article-title":"Role of the renin-angiotensin system in vascular diseases: expanding the field","volume":"38","author":"Ruiz-Ortega","year":"2001","journal-title":"Hypertension."},{"key":"B244","doi-asserted-by":"publisher","first-page":"e00611","DOI":"10.1128\/MCB.00611-16","article-title":"Myocyte-derived Hsp90 modulates collagen upregulation via biphasic activation of STAT-3 in fibroblasts during cardiac hypertrophy","volume":"37","author":"Datta","year":"2017","journal-title":"Mol Cell Biol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11897-014-0219-3","article-title":"New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction","volume":"11","author":"Tsch\u00f6pe","year":"2014","journal-title":"Curr Heart Fail Rep."},{"key":"B246","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","article-title":"Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases","volume":"99","author":"Piera-Velazquez","year":"2019","journal-title":"Physiol Rev."},{"key":"B247","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","article-title":"The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality","volume":"28","author":"Chaudhuri","year":"2018","journal-title":"Cell Metab."},{"key":"B248","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11897-012-0089-5","article-title":"Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure","volume":"9","author":"Ramasamy","year":"2012","journal-title":"Curr Heart Fail Rep."},{"key":"B249","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s12276-021-00561-7","article-title":"Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury","volume":"53","author":"Rungratanawanich","year":"2021","journal-title":"Exp Mol Med."},{"key":"B250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0037-1613678","article-title":"AGE-RAGE stress, stressors, and antistressors in health and disease","volume":"27","author":"Prasad","year":"2018","journal-title":"Int J Angiol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B252","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1161\/CIRCRESAHA.111.262493","article-title":"Adipose tissue biology and cardiomyopathy: translational implications","volume":"111","author":"Turer","year":"2012","journal-title":"Circ Res."},{"key":"B253","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.yjmcc.2006.05.001","article-title":"An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1","volume":"41","author":"Rajapurohitam","year":"2006","journal-title":"J Mol Cell Cardiol."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1111\/j.1582-4934.2010.01154.x","article-title":"Inhibition of cardiac leptin expression after infarction reduces subsequent dysfunction","volume":"15","author":"Moro","year":"2011","journal-title":"J Cell Mol Med."},{"key":"B256","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1530\/eje.0.1470173","article-title":"Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women","volume":"147","author":"Matsubara","year":"2002","journal-title":"Eur J Endocrinol."},{"key":"B257","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation."},{"key":"B258","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat Med."},{"key":"B259","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.115.307856","article-title":"Mutual regulation of epicardial adipose tissue and myocardial redox state by PPAR-\u03b3\/adiponectin signalling","volume":"118","author":"Antonopoulos","year":"2016","journal-title":"Circ Res."},{"key":"B260","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s10517-017-3860-5","article-title":"Adipokine and cytokine profiles of epicardial and subcutaneous adipose tissue in patients with coronary heart disease","volume":"163","author":"Gruzdeva","year":"2017","journal-title":"Bull Exp Biol Med."},{"key":"B261","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1161\/CIRCULATIONAHA.111.039586","article-title":"Secretory products from epicardial adipose tissue of patients with type 2 diabetes mellitus induce cardiomyocyte dysfunction","volume":"126","author":"Greulich","year":"2012","journal-title":"Circulation."},{"key":"B262","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cjca.2017.08.001","article-title":"Relationships between periventricular epicardial adipose tissue accumulation, coronary microcirculation, and left ventricular diastolic dysfunction","volume":"33","author":"Nakanishi","year":"2017","journal-title":"Can J Cardiol."},{"key":"B263","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.echo.2011.09.018","article-title":"Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography","volume":"25","author":"Lai","year":"2012","journal-title":"J Am Soc Echocardiogr."},{"key":"B264","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10741-017-9644-1","article-title":"Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease","volume":"22","author":"Patel","year":"2017","journal-title":"Heart Fail Rev."},{"key":"B265","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.amjcard.2014.08.037","article-title":"Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions in patients after myocardial infarction","volume":"114","author":"Fontes-Carvalho","year":"2014","journal-title":"Am J Cardiol."},{"key":"B266","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.12.045","article-title":"Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study","volume":"55","author":"Kalogeropoulos","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B267","doi-asserted-by":"publisher","first-page":"e018549","DOI":"10.1161\/JAHA.120.018549","article-title":"Interleukin 6 and development of heart failure with preserved ejection fraction in the general population","volume":"10","author":"Chia","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jacc.2018.06.050","article-title":"Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction","volume":"72","author":"Tromp","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"e003989","DOI":"10.1161\/JAHA.116.003989","article-title":"Biomarker profiles in heart failure patients with preserved and reduced ejection fraction","volume":"6","author":"Tromp","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B270","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40273-014-0243-x","article-title":"The epidemiology of obesity: a big picture","volume":"33","author":"Hruby","year":"2015","journal-title":"Pharmacoeconomics."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.742178\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T00:52:28Z","timestamp":1633308748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.742178\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,4]]},"references-count":270,"alternative-id":["10.3389\/fcvm.2021.742178"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.742178","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,4]]},"article-number":"742178"}}